Transplant Recipient Clinical Trials

2 recruiting

Transplant Recipient Trials at a Glance

29 actively recruiting trials for transplant recipient are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Boston, Toronto, and Bologna. Lead sponsors running transplant recipient studies include University Health Network, Toronto, City of Hope Medical Center, and IRCCS Azienda Ospedaliero-Universitaria di Bologna.

Browse transplant recipient trials by phase

Treatments under study

About Transplant Recipient Clinical Trials

Looking for clinical trials for Transplant Recipient? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Transplant Recipient trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Transplant Recipient clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 29 trials

Recruiting
Phase 2

The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients

Kidney Transplant Recipients
University Health Network, Toronto20 enrolled1 locationNCT05938712
Recruiting

University of Minnesota Transplant Registry

Transplant RecipientTransplant Donation
University of Minnesota10,000 enrolled1 locationNCT01062581
Recruiting

Vascular Complications After Kidney Transplantation

Heart FailureKidney Transplant; ComplicationsRenovascular Hypertension+4 more
University of Aarhus60 enrolled3 locationsNCT07531966
Recruiting
Not Applicable

Diode Laser-Assisted Periodontal Therapy in Kidney Transplant Recipients

PeriodontitisKidney Transplant Recipients
Military Hospital 10380 enrolled2 locationsNCT07532694
Recruiting
Phase 3

Shingrix in Renal Transplant Recipients

Kidney FailureKidney TransplantationKidney Failure, Chronic+2 more
University of Colorado, Denver132 enrolled4 locationsNCT04128189
Recruiting
Phase 2

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Allogeneic Stem Cell Transplant Recipient
Hackensack Meridian Health209 enrolled3 locationsNCT07214688
Recruiting
Early Phase 1

Pilot Trial of Supplemental Vitamin A and Nicotinamide

Skin CancerKidney Transplant Recipients
Rhode Island Hospital30 enrolled1 locationNCT05702398
Recruiting
Phase 4

Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients

Old AgeKidney Transplant Recipients
Massachusetts General Hospital92 enrolled1 locationNCT06751992
Recruiting
Phase 4

Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients

CMVLung Transplant Recipient
University Health Network, Toronto40 enrolled1 locationNCT07235683
Recruiting
Not Applicable

Velocity-Based Resistance Training in Kidney Transplant Recipients

Metabolic SyndromeCardiovascular Risk FactorsKidney Transplant Recipients
Fundación Universitaria del Area Andina12 enrolled1 locationNCT07370727
Recruiting

Liver Transplant Recipients and 30-Second Lie-to-Sit Test

Liver Transplant Recipients
Inonu University34 enrolled1 locationNCT07365098
Recruiting

"Duration of Preoperative Clear Fluids Fasting in Patients Undergoing Liver Transplant"

Preoperative Clear Fluid FastingLiver Transplant Recipient
Medical University of Warsaw100 enrolled1 locationNCT07288281
Recruiting

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

Kidney TransplantKidney DiseaseTransplant Recipient+1 more
Devyser Inc.400 enrolled6 locationsNCT07006831
Recruiting
Phase 1

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

Hematopoietic and Lymphoid Cell NeoplasmAllogeneic Hematopoietic Stem Cell Transplant Recipient
City of Hope Medical Center53 enrolled1 locationNCT04177004
Recruiting
Phase 4

Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

Hepatitis B Virus (HBV)Lung Transplant Recipient
University Health Network, Toronto20 enrolled1 locationNCT07189377
Recruiting
Phase 1Phase 2

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

Cytomegaloviral InfectionHematopoietic Cell Transplant Recipient
City of Hope Medical Center80 enrolled1 locationNCT03354728
Recruiting
Early Phase 1

Tolerance Through Mixed Chimerism (Sip-Tego)

Kidney FailureTransplant Recipient (Kidney)Immunosuppresion+2 more
Tatsuo Kawai, MD, PhD12 enrolled1 locationNCT06972069
Recruiting
Phase 4

Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus

Kidney Disease, ChronicImmunosuppressionTransplant Recipient (Kidney)
Instituto de Investigación Hospital Universitario La Paz114 enrolled1 locationNCT06701825
Recruiting

Multimodal Ultrasound in DBD Kidneys for Predicting Early Postoperative Renal Insufficiency Risk

Occurrence of Renal Dysfunction (GFR ≤ 60mL/(Min·1.73m2)) in Renal Transplant Recipients Within One Year After Kidney Transplantation
Bei Wang27 enrolled1 locationNCT07090512
Recruiting

Bronchial Response to Exercise After Double Lung Transplantation

Lung TransplantLung Transplant RecipientsAirway Response+1 more
Chang Gung Memorial Hospital40 enrolled1 locationNCT07035743